FI853211A7 - D-6-/ -/(2-okso-3-furfurylideeni-amino -imidatsoliini-1-yyli)karbonyyliamino/-tienyyli-2-asetamido/ -penisillaanihapon kiteinen natriumsuola, menetelmä sen valmistamiseksja sen käyttö lääkeaineissa. - Google Patents

D-6-/ -/(2-okso-3-furfurylideeni-amino -imidatsoliini-1-yyli)karbonyyliamino/-tienyyli-2-asetamido/ -penisillaanihapon kiteinen natriumsuola, menetelmä sen valmistamiseksja sen käyttö lääkeaineissa. Download PDF

Info

Publication number
FI853211A7
FI853211A7 FI853211A FI853211A FI853211A7 FI 853211 A7 FI853211 A7 FI 853211A7 FI 853211 A FI853211 A FI 853211A FI 853211 A FI853211 A FI 853211A FI 853211 A7 FI853211 A7 FI 853211A7
Authority
FI
Finland
Prior art keywords
furfurylidene
imidazolin
carbonylamino
acetamido
thienyl
Prior art date
Application number
FI853211A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI853211L (fi
FI853211A0 (fi
Inventor
Hans-Bode König
Karl Georg Metzger
Wilfried Schröck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI853211A0 publication Critical patent/FI853211A0/fi
Publication of FI853211L publication Critical patent/FI853211L/fi
Publication of FI853211A7 publication Critical patent/FI853211A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/70—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI853211A 1984-08-25 1985-08-21 D-6-/ -/(2-okso-3-furfurylideeni-amino -imidatsoliini-1-yyli)karbonyyliamino/-tienyyli-2-asetamido/ -penisillaanihapon kiteinen natriumsuola, menetelmä sen valmistamiseksja sen käyttö lääkeaineissa. FI853211A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843431273 DE3431273A1 (de) 1984-08-25 1984-08-25 Kristallines natriumsalz der d-6-((alpha)-(2-oxo-3-furfuryl-iden-amino-imidazolidin-1-yl)-carbonylamino)-thienyl-2-acetamido)-penicillansaeure, verfahren zur herstellung und seine verwendung in arzneimitteln
CN85106479A CN85106479B (zh) 1984-08-25 1985-08-29 晶状的右旋-6-{α-[(2-氧代-3-亚糠基-氨基-咪唑烷-1-基)碳酰氨基]-2-噻吩基乙酰氨基}-青霉烷酸钠盐制备方法

Publications (3)

Publication Number Publication Date
FI853211A0 FI853211A0 (fi) 1985-08-21
FI853211L FI853211L (fi) 1986-02-26
FI853211A7 true FI853211A7 (fi) 1986-02-26

Family

ID=25741999

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853211A FI853211A7 (fi) 1984-08-25 1985-08-21 D-6-/ -/(2-okso-3-furfurylideeni-amino -imidatsoliini-1-yyli)karbonyyliamino/-tienyyli-2-asetamido/ -penisillaanihapon kiteinen natriumsuola, menetelmä sen valmistamiseksja sen käyttö lääkeaineissa.

Country Status (18)

Country Link
EP (1) EP0176716B1 (enExample)
JP (1) JPS6157589A (enExample)
KR (1) KR860001818A (enExample)
CN (1) CN85106479B (enExample)
AT (1) ATE34576T1 (enExample)
AU (1) AU559040B2 (enExample)
DE (2) DE3431273A1 (enExample)
DK (1) DK385085A (enExample)
ES (1) ES8609340A1 (enExample)
FI (1) FI853211A7 (enExample)
GR (1) GR852047B (enExample)
HU (1) HU194893B (enExample)
IL (1) IL76164A0 (enExample)
NO (1) NO853188L (enExample)
NZ (1) NZ213198A (enExample)
PH (1) PH21842A (enExample)
PT (1) PT81014B (enExample)
ZA (1) ZA856413B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW347383B (en) * 1995-10-26 1998-12-11 Biochemie Gmbh A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL85039B1 (pl) * 1972-02-17 1977-02-26 Tarchomińskie Zakłady Farmaceutyczne Sposób wytwarzania soli sodowej a-ftminobenzylopeiiicylmy
PL87153B1 (pl) * 1973-07-13 1976-12-15 Tarchomińskie Zakłady Farmaceutyczne Sposób otrzymywania krystalicznej soli dwusodowej penicyliny a-karboksybenzylowej
DE2732283A1 (de) * 1977-07-16 1979-01-25 Bayer Ag Beta-lactam-verbindungen
DE2732323A1 (de) * 1977-07-16 1979-01-25 Bayer Ag Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung
JPS5940727A (ja) * 1982-07-28 1984-03-06 Fujitsu Ltd 自動等化方式

Also Published As

Publication number Publication date
ZA856413B (en) 1986-04-30
PT81014A (en) 1985-09-01
FI853211L (fi) 1986-02-26
HUT38354A (en) 1986-05-28
AU4657785A (en) 1986-02-27
NZ213198A (en) 1989-02-24
NO853188L (no) 1986-02-26
IL76164A0 (en) 1985-12-31
AU559040B2 (en) 1987-02-19
EP0176716A1 (de) 1986-04-09
KR860001818A (ko) 1986-03-22
GR852047B (enExample) 1985-12-20
HU194893B (en) 1988-03-28
ES546379A0 (es) 1986-07-16
PT81014B (pt) 1987-12-30
CN85106479B (zh) 1988-07-27
ATE34576T1 (de) 1988-06-15
JPS6157589A (ja) 1986-03-24
DE3431273A1 (de) 1986-03-06
ES8609340A1 (es) 1986-07-16
DK385085D0 (da) 1985-08-23
EP0176716B1 (de) 1988-05-25
FI853211A0 (fi) 1985-08-21
DE3562918D1 (en) 1988-06-30
DK385085A (da) 1986-02-26
CN85106479A (zh) 1987-03-18
PH21842A (en) 1988-03-17

Similar Documents

Publication Publication Date Title
FI875484A7 (fi) Fosfinsyraderivat.
FI853626A7 (fi) Isoksatsolikarboksyylihappojohdannaiset, niiden valmistus ja käyttö.
FI823026A7 (fi) Ureajohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä sekä näiden käyttö.
FI830378A7 (fi) Pyratsolioksatsiinit, -tiatsiinit, - kinoliinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeainlääkeaineina.
GR3001210T3 (en) Thiolactam-n-acetic acid derivatives, their production and use
DE3576335D1 (de) Chinolincarbonsaeure-derivate.
DK166211C (da) Krystalliseret cephem-syreadditionssalt, dets fremstilling og anvendelse
ATE34383T1 (de) Oxamidsaeure-derivate.
FI863597A7 (fi) Menetelmä tetrafluoribentsoehapon valmistamiseksi.
FI820061A7 (fi) Uudet karboksyylihappoamidit, niiden valmistus ja niiden käyttö lääkeaineina.
DE3787657D1 (de) Aminosäure-Derivate.
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
FI820060A7 (fi) Uudet karboksyylihappo-johdannaiset, niiden valmistus ja niiden käyttö lääkeaineina.
DE3483294D1 (de) Barbitursaeurederivate.
FI803202A7 (fi) Fosfonohydroksietikkahappo, sen valmistusmenetelmä sekä käyttö lääkeaineena.
FI860167A7 (fi) Aminoakryylihappo-johdannaisia.
FI874309A7 (fi) Salisyylihappoamideja, menetelmä niiden valmistamiseksi ja niiden käyttö
FI875051A7 (fi) Menetelmä kromogeenisia materiaaleja sisältävien vesiliuosten valmistamiseksi.
NO884361L (no) Katechol-karboksylsyrederivater.
FI873800A7 (fi) Nor-kolaanihappojohdannaiset, menetelmä niiden valmistamiseksi, niiden käyttö sekä niitä sisältävät farmaseuttiset seokset.
FI842112L (fi) Foerfarande foer framstaellning av -karbolin-3-karboxylsyraderivat.
DE3679100D1 (de) Cyanalkankarbonsaeureimidamid-verbindungen.
DK166353C (da) Penicillansyre-1,1-dioxid-derivater
FI884225A7 (fi) Uusia aminohappoestereitä, menetelmiä niiden valmistamiseksi, niitä sisältäviä lääkeaineita ja niiden käyttö.
FI822236A7 (fi) Uudet imidatso/1,2-a/pyrimidiinit, niiden happoadditiosuolat, niitä sisältävät lääkeaineet ja niiden valmvalmistusmenetelmät.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BAYER AKTIENGESELLSCHAFT